Skip to content
Home/Companies/MedTech/Aesynt

Aesynt

MedTech·USA·Exited 2016
Entry
–
Hold
–
Exit
2016

Who owns Aesynt?

Aesynt is an American MedTech company, now owned by Omnicell, which acquired it in 2016 from Francisco Partners.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Francisco Partners
Investor
Francisco Partners
Francisco Partners V, L.P. · 2017 · Buyout

Key facts

HQUSA
SectorMedTech
Exit Type
Trade Sale
Buyer
Omnicell
Exit Year
2016

More from Francisco Partners V, L.P.

Other portfolio companies in the same fund.

2Checkout (Avangate)
Exited
E-commerceUS
to Verifone
Aeries Software
Aeries Software
Active
TMTUS
Attachmate
Exited 2014
IndustrialsUS
to Micro Focus
Availity
Availity
Exited 2021
HealthTechUS
to Novo Holdings
Avalon
Avalon
Active
TMTUS
BARBRI
Barbri
Active
EducationUS

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Appasamy
Appasamy
Active
Warburg PincusIndia

Questions

Who owns Aesynt?

Aesynt is now owned by Omnicell, which acquired it in 2016 from Francisco Partners.

When did Omnicell acquire Aesynt?

Omnicell acquired Aesynt in 2016, buying from Francisco Partners.

Who did Aesynt sell to?

Francisco Partners sold Aesynt to Omnicell in 2016 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue